Literature DB >> 33904379

A case of multisystem inflammatory syndrome in children in a Japanese boy: with discussion of cytokine profile.

Sayaka Fukuda1, Mio Kaneta1, Mayuko Miyake2, Takashi Ohya2, Kei Miyakawa3, Mari Iwamoto1, Shuichi Ito2.   

Abstract

The new disease concept of multisystem inflammatory syndrome in children (MIS-C), which is a systemic inflammatory syndrome with multiple organ involvement after SARS-CoV2 infection, was established in 2020. MIS-C is common in Hispanic and black children in Europe and North America, with few reports in East Asians. A significant portion of patients with MIS-C develop Kawasaki disease (KD)-like symptoms. Therefore, differential diagnosis is challenging, especially in East Asia, where KD is most prevalent. No Japanese cases have been reported in the literatures so far. We report a case of MIS-C in Japan with KD-like symptoms. A 9-year-old Japanese boy, who was infected with SARS-CoV2 1 month previously along with his family, was admitted to our hospital owing to fever for 6 d and erythema mainly in the groyne and pubic area. He also had conjunctivitis, strawberry tongue and diarrhoea. His laboratory findings were as follows: WBC, 12,840/µL (lymphocytes, 4%); CRP, 22.6 mg/dL, pro-calcitonin, 1.8 ng/mL (normal, <0.50 ng/mL); NT pro-BNP, 7627 pg/mL (<125 pg/mL); and troponin T, 0.14 ng/mL (<0.01 ng/mL). His cardiac function was normal. We initially diagnosed him with KD. His fever rapidly resolved with intravenous immunoglobulin (IVIG) and there were no coronary artery lesions. Desquamation of the fingers was observed later. Finally, a history of SARS-COV2 infection, his age, atypical skin rash, elevation of markers of inflammation and heart failure and lymphopenia suggested the diagnosis of MIS-C rather than KD. Differentiation between KD and MIS-C is necessary even in Japan, especially in patients with atypical features of KD.

Entities:  

Keywords:  Japanese; Kawasaki disease; Multisystem inflammatory syndrome in children; SARS-CoV2; paediatric inflammatory multisystem syndrome temporally associated with SARS-CoV2

Year:  2021        PMID: 33904379     DOI: 10.1080/24725625.2021.1920140

Source DB:  PubMed          Journal:  Mod Rheumatol Case Rep        ISSN: 2472-5625


  8 in total

1.  Changes in the Clinical Characteristics of Kawasaki Disease After Coronavirus Disease (COVID-19) Pandemic: A Database Analysis.

Authors:  Kyunghoon Kim; Hyun Hee Kim; Beom Joon Kim; Arum Choi; Hwan Soo Kim; Jin-Hee Oh; Jae-Young Lee; Sukil Kim; Ji-Whan Han
Journal:  J Korean Med Sci       Date:  2022-05-23       Impact factor: 5.354

Review 2.  SARS-CoV-2 infections in children: Understanding diverse outcomes.

Authors:  Petter Brodin
Journal:  Immunity       Date:  2022-01-20       Impact factor: 31.745

3.  Infliximab treatment for refractory COVID-19-associated multisystem inflammatory syndrome in a Japanese child.

Authors:  Yohei Yamaguchi; Kei Takasawa; Hitoshi Irabu; Kanako Hiratoko; Yosuke Ichigi; Ko Hirata; Yumie Tamura; Miki Murakoshi; Motoi Yamashita; Hisae Nakatani; Masuhiro Shimoda; Taku Ishii; Tomohiro Udagawa; Masaki Shimizu; Hirokazu Kanegane; Tomohiro Morio
Journal:  J Infect Chemother       Date:  2022-01-24       Impact factor: 2.065

4.  COVID-19 associated multisystemic inflammatory syndrome in 614 children with and without overlap with Kawasaki disease-Turk MIS-C study group.

Authors:  Dilek Yilmaz Ciftdogan; Yildiz Ekemen Keles; Benhur Sirvan Cetin; Nazan Dalgic Karabulut; Melike Emiroglu; Zafer Bagci; Ayse Buyukcam; Emine Hafize Erdeniz; Gul Arga; Edanur Yesil; Ozlem Cakici; Adem Karbuz; Zumrut Sahbudak Bal; Soner Sertan Kara; Arife Ozer; Ozge Metin Akcan; Sefika Elmas Bozdemir; Ayse Berna Anil; Hatice Uygun; Omer Kilic; Selda Hancerli Torun; Zuhal Umit; Murat Sutcu; Berfin Ozgokce Ozmen; Hatice Karaoglu Asrak; Gulsum Alkan; Ahu Kara Aksay; Cuneyt Ugur; Ahmet Ziya Birbilen; Burcu Bursal Duramaz; Esra Akyuz Ozkan; Ozgur Burakay; Sema Yildirim Arslan; Eda Karadag Oncel; Serkan Fazli Celik; Ahmet Osman Kilic; Seval Ozen; Remzi Sarikaya; Demet Demirkol; Gazi Arslan; Ozden Turel; Ahmet Sert; Ergul Sari; Zerrin Orbak; Irfan Oguz Sahin; Celal Varan; Hacer Akturk; Sadiye Kubra Tuter Oz; Fatih Durak; Mehmet Burhan Oflaz; Manolya Kara; Derya Karpuz; Mey Talip Petmezci; Nevin Hatipoglu; Selim Oncel; Mehmet Turgut; Ferhan Elmali; Ayper Somer; Necdet Kuyucu; Ener Cagri Dinleyici; Zafer Kurugöl; Ergin Ciftci; Ates Kara
Journal:  Eur J Pediatr       Date:  2022-02-07       Impact factor: 3.860

5.  A young child with pediatric multisystem inflammatory syndrome successfully treated with high-dose immunoglobulin therapy.

Authors:  Yosuke Mohri; Mariko Shimizu; Tadao Fujimoto; Yuki Nishikawa; Akiko Ikeda; Yusuke Matsuda; Taizo Wada; Chiharu Kawaguchi
Journal:  IDCases       Date:  2022-03-31

Review 6.  Updates on Coronavirus Disease 2019 in Children in Japan.

Authors:  Yuta Aizawa; Sayaka Takanashi; Chikara Ogimi
Journal:  Pediatr Infect Dis J       Date:  2022-07-18       Impact factor: 3.806

7.  The clinical characteristics of pediatric coronavirus disease 2019 in 2020 in Japan.

Authors:  Tomohiro Katsuta; Naoki Shimizu; Kenji Okada; Keiko Tanaka-Taya; Takashi Nakano; Hajime Kamiya; Kiyoko Amo; Naruhiko Ishiwada; Satoshi Iwata; Makoto Oshiro; Nobuhiko Okabe; Ryutaro Kira; Seigo Korematsu; Shigeru Suga; Takeshi Tsugawa; Naoko Nishimura; Haruka Hishiki; Masashi Fujioka; Mitsuaki Hosoya; Yumi Mizuno; Mahito Mine; Isao Miyairi; Chiaki Miyazaki; Ichiro Morioka; Tsuneo Morishima; Tetsushi Yoshikawa; Taizo Wada; Hiroshi Azuma; Koichi Kusuhara; Kazunobu Ouchi; Akihiko Saitoh; Hiroyuki Moriuchi
Journal:  Pediatr Int       Date:  2021-11-10       Impact factor: 1.617

8.  Multisystem Inflammatory Syndrome in Children (MIS-C) Without Antecedent Clinical Symptoms Related to COVID-19: The Increasing Importance of Distinguishing MIS-C in Patients with Kawasaki Disease-Like Features.

Authors:  Masato Ozaki; Tomohiro Hori; Yuki Miwa; Takahiro Yamamoto; Kazuo Kubota; Minako Kawamoto; Norio Kawamoto; Hidenori Ohnishi
Journal:  Mod Rheumatol Case Rep       Date:  2022-02-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.